The Journal of Infectious Diseases · 1999 · 36 citations · 23 references
MedicineInfectious DiseasesPediatricsInfant HealthPediatric Infectious DiseasesVirologyHiv EpidemiologyHiv TestingInfant Infectious DiseasesNeonatal InfectionsNeonatal Infectious DiseasesPerinatal InfectionDried Blood Spot AnalysisDried Blood Spot SamplingHiv Infection In InfantsMaternal Human Immunodeficiency Virus InfectionNeonatal Viral InfectionNucleic Acid AmplificationPrenatal Hiv TestingViral Infections In Newborns
In developed areas, human immunodeficiency virus (HIV)-infected infants have high virus levels and rapidly progress to death. HIV levels were assessed in 1994-1997 in untreated infants in Malawi by analysis of dried blood spots tested by nucleic acid silica-bound amplification. Of 24 umbilical cord blood (CB)-positive samples, 83% had >10,000 copies/mL. The median virus level was 78,000 copies/mL. First positive sample median levels were 355,000 copies/mL among 52 perinatally infected infants and 130,000 copies/mL among 43 infants infected by breast-feeding. Virus levels were stable, and initial levels predicted levels 1 year after infection (P=.005), at which time levels did not significantly differ among in utero, perinatally, or postnatally infected infants. Thus, neither age at infection nor route of infection significantly influenced HIV levels measured 1 year after infection. Most (87%) CB-positive infants were infected before labor onset, since virus levels greatly exceeded those expected in their mothers.
23